Alector logo

Alector Share Price Today

(NASDAQ: ALEC)

Alector share price is $1.3 & ₹111.35 as on 27 Mar 2025, 2.30 'hrs' IST

$1.3

0.01

(0.78%)

Market is closed - opens 7 PM, 27 Mar 2025

View live Alector share price in Dollar and Rupees. Guide to invest in Alector stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Alector, along with analyst recommendations, forecasts, and comprehensive financials.

Alector share price movements

  • Today's Low: $1.26
    Today's High: $1.33

    Day's Volatility :5.26%

  • 52 Weeks Low: $1.26
    52 Weeks High: $6.78

    52 Weeks Volatility :81.42%

Alector (ALEC) Returns

PeriodAlector IncSector (Health Care)Index (Russel 2000)
3 Months
-28.57%
4.2%
0.0%
6 Months
-72.97%
-5.4%
0.0%
1 Year
-78.62%
-2.0%
0.0%
3 Years
-91.03%
6.2%
-14.9%

Alector (ALEC) Key Statistics

in dollars & INR

Previous Close
$1.29
Open
$1.29
Today's High
$1.33
Today's Low
$1.26
Market Capitalization
$128.8M
Today's Volume
$328.1K
52 Week High
$6.78
52 Week Low
$1.26
Revenue TTM
$100.6M
EBITDA
$-137.4M
Earnings Per Share (EPS)
$-1.23
Profit Margin
-118.39%
Quarterly Earnings Growth YOY
-0.86%
Return On Equity TTM
-91.24%

How to invest in Alector Stock (ALEC) from India?

It is very easy for Indian residents to invest directly in Alector from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Alector stock in both Indian Rupees (INR) and US Dollars (USD). Search for Alector or ALEC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Alector or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Alector shares which would translate to 0.659 fractional shares of Alector as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Alector, in just a few clicks!

Returns in Alector (ALEC) for Indian investors in Rupees

The Alector stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Alector investment value today

Current value as on today

₹24,163

Returns

₹75,837

(-75.84%)

Returns from Alector Stock

₹78,618 (-78.62%)

Dollar Returns

₹2,782 (+2.78%)

Indian investors sentiment towards Alector (ALEC)

38%

Period: Feb 24, 2025 to Mar 26, 2025. Change in 30 Days versus previous period

Search interest for Alector Stock from India on INDmoney has increased by 38% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Alector

  • FMR Inc

    14.83%

  • RA Capital Management, LLC

    9.78%

  • BlackRock Inc

    9.22%

  • Vanguard Group Inc

    5.67%

  • Merck & Co Inc

    3.58%

  • Geode Capital Management, LLC

    1.93%

Analyst Recommendation on Alector

Buy

    76%Buy

    17%Hold

    5%Sell

Based on 17 Wall street analysts offering stock ratings for Alector(by analysts ranked 0 to 5 stars)

Based on 17 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
14
14
Hold
3
3
3
Sell
1
1
1

Analyst Forecast on Alector Stock (ALEC)

What analysts predicted

Upside of 224.84%

Target:

$4.22

Current:

$1.30

Insights on Alector Stock (Ticker Symbol: ALEC)

  • Price Movement

    In the last 1 month, ALEC stock has moved down by -21.7%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 15.08M → 54.24M (in $), with an average increase of 36.7% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -42.22M → -2.07M (in $), with an average increase of 1935.7% per quarter
  • ALEC vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 74.4% return, outperforming this stock by 153.0%
  • ALEC vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 64.3% return, outperforming this stock by 155.3%
  • Price to Sales

    ForALEC every $1 of sales, investors are willing to pay $1.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $15.3 for every $1 of sales.

Alector Technicals Summary

Sell

Neutral

Buy

Alector is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Alector (ALEC) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Alector Inc logo
-26.55%
-72.97%
-78.62%
-91.03%
-94.69%
Regeneron Pharmaceuticals, Inc. logo
-11.52%
-38.45%
-33.75%
-7.68%
35.34%
Beone Medicines Ltd logo
-3.38%
18.06%
61.8%
27.75%
100.11%
Vertex Pharmaceuticals Incorporated logo
4.15%
8.02%
19.88%
95.64%
115.71%
Alnylam Pharmaceuticals, Inc. logo
9.79%
-1.95%
74.37%
66.54%
147.37%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Alector Inc logo
15.47
NA
NA
-1.97
-0.91
-0.16
NA
1.28
Regeneron Pharmaceuticals, Inc. logo
16.53
16.53
0.94
42.62
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.45
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.44
18.06
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.83
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Alector Inc logo
Buy
$128.8M
-94.69%
15.47
-118.39%
Regeneron Pharmaceuticals, Inc. logo
Buy
$72.3B
35.34%
16.53
31.07%
Beone Medicines Ltd logo
NA
$28.5B
100.11%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$131.4B
115.71%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$37.6B
147.37%
NA
-12.37%

About Alector

Alector, Inc., a late-stage clinical biotechnology company, develops therapies that is focused on counteracting the devastating progression of neurodegenerative diseases. The company's products under development include Latozinemab (AL001), an investigational human recombinant monoclonal antibody designed to elevate progranulin (PGRN), a protein encoded by the granulin (GRN) gene that regulates lysosomal function, neuronal survival, and inflammation in the brain. Its lead PGRN-elevating candidate is being developed for the potential treatment of frontotemporal dementia with a granulin gene mutation (FTD-GRN) which is caused by heterozygous loss-of-function (LOF) mutations in the GRN gene and results in PGRN haploinsufficiency and is in Phase 3 clinical trial. It also develops AL101/GSK4527226 that is in Phase 2 clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. In addition, the company's preclinical and research pipeline products include ADP037-ABC, a proprietary anti-amyloid beta (Aß) antibody paired with proprietary ABC for the treatment of AD; ADP050-ABC, a GCase replacement therapy paired with proprietary ABC for GBA gene mutation carriers with Parkinson's disease and Lewy body dementia; ADP056, a Reelin modulator designed to block tau pathology and promote synaptic function in AD; and ADP063-ABC and ADP064-ABC that are therapeutic candidates paired with proprietary ABC that target tau pathology in AD through distinct approaches. It has a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of progranulin-elevating monoclonal antibodies, including latozinemab and AL101 to treat neurodegenerative diseases. The company was founded in 2013 and is headquartered in South San Francisco, California.
Organization
Alector
Employees
238
CEO
Dr. Arnon Rosenthal Ph.D.
Industry
Biotechnology

Management People of Alector

NameTitle
Dr. Arnon Rosenthal Ph.D.
Co-Founder, CEO & Director
Dr. Saraswati Kenkare-Mitra Ph.D.
President and Head of Research & Development
Dr. Marc Grasso M.D.
CFO, Principal Financial Officer & Principal Accounting Officer
Dr. Gary Romano M.D., Ph.D.
Chief Medical Officer
Ms. Katie Hogan
Senior Director of Corporate Communication & Investor Relations
Ms. Danielle Pasqualone J.D., Ph.D.
General Counsel
Ms. Clare Hunt M.B.A.
Chief People Officer
Ms. Kristina Cutter M.P.H.
Chief Regulatory, Pharmacovigilance, & Quality Assurance Officer
Ms. Virginia DeJesus-Rueff M.B.A.
Chief of Staff & Head of Strategy
Mr. Neil Berkley M.B.A., M.S.
Chief Business Officer

Important FAQs about investing in ALEC Stock from India :

What is Alector share price today?

Alector share price today stands at $1.30, Open: $1.29 ; Previous Close: $1.29 ; High: $1.33 ; Low: $1.26 ; 52 Week High: $6.78 ; 52 Week Low: $1.26.

The stock opens at $1.29, after a previous close of $1.29. The stock reached a daily high of $1.33 and a low of $1.26, with a 52-week high of $6.78 and a 52-week low of $1.26.

Can Indians buy Alector shares?

Yes, Indians can invest in the Alector (ALEC) from India.

With INDmoney, you can buy Alector at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Alector at zero transaction cost.

How can I buy Alector shares from India?

It is very easy to buy Alector from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Alector (ALEC) be purchased?

Yes, you can buy fractional shares of Alector with INDmoney app.

What are the documents required to start investing in Alector stocks?

To start investing in Alector, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Alector Stock (ALEC)?

Today’s highest price of Alector (ALEC) is $1.33.

Today’s lowest price of Alector (ALEC) is $1.26.

What is today's market capitalisation of Alector?

Today's market capitalisation of Alector ALEC is 128.8M

What is the 52 Week High and Low Range of Alector Stock (ALEC)?

  • 52 Week High

    $6.78

  • 52 Week Low

    $1.26

What are the historical returns of Alector (ALEC)?

  • 1 Month Returns

    -26.55%

  • 3 Months Returns

    -72.97%

  • 1 Year Returns

    -78.62%

  • 5 Years Returns

    -94.69%

Who is the Chief Executive Officer (CEO) of Alector ?

Dr. Arnon Rosenthal Ph.D. is the current Chief Executive Officer (CEO) of Alector.